EichorEICHOR
Location: Boerne Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Boerne

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · TTS Research · Uniquity One (UNI) · NCT06496620A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Phase 1 · TTS Research · Genentech, Inc. · NCT06603246Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-Hi
Phase 2 · Research Site · AstraZeneca · NCT06932263A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · South Texas Medical Research Institute, Inc., dba TTS Resear · Hoffmann-La Roche · NCT05878769Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY A
Phase 3 · South Texas Medical Research Institute - TTS Research- Site · Sanofi · NCT06191315A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Gastroenterology Research of Hill Country · Gilead Sciences · NCT06029972MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Advanced Surgical Care of Boerne · Stryker Instruments · NCT03072927A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Phase 2 · South Texas Medical Research Institute, Inc., DBA TTS Resear · Pfizer · NCT06977581Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · South Texas Medical Research Institute - TTS Research- Site · Sanofi · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06878261A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderat
Phase 2 · Copd01 50001 · UCB Biopharma SRL · NCT07725939A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · South Texas Medical Research Institute, Inc., DBA TTS Resear · Pfizer · NCT07363694
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.